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A B S T R A C T
The aim of this study is to analyze the morphologic and functional change of human bone defect after its grafting with
mixture of platelet gel and autologous cancellous bone. For one year, we have prospectively studied nine consecutive pa-
tients, aged 25–73 y, with pseudoarthrosis of long bones, after unsuccessful initial surgeries. We have harvested can-
cellous bone from patients’ iliac crests and mixed with the ABO compatible allogeneic platelet rich plasma (PRP) gel.
That mixture has been inserted in the bone defect, and surgically fixated. Radiologically, the defects achieved the bone
morphology (the appearance of hazy callus) between 6th and 24th week. The time of functional recovery was varied, be-
tween 12 and 40 weeks for partial weight bearing, and between 16 and 48 weeks for free limb mobility and full function of
the limb. The overall healing of bone defect was 16 to 36 weeks. Two patients had complications of poor graft ingrowth
and one with a reversible postsurgical nerve paresis. On the X-ray scans, solid and fast restoration of bone structure was
notable, with excellent bone ingrowth, suitable for full weight bearing. The allogeneic platelet gel had no adverse effects.
This method can be used for treating of long bone defects, because of its strong influence on restoration of normal bone
morphology. Further investigation is required to establish efficiency relative to other methods.
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Introduction
The extensive trauma and subsequent infection can
cause large bone defects. Structural properties of dis-
eased bone are presented as a diminished mineralization,
lower protein composition, and unnatural distribution of
the bone trabecullae. This all leads to brittle bony mor-
phology and inadequate resistance to regular mechanic
stress.
The bone defects can be treated by various surgical
methods. The most common methods are reconstruc-
tions by cancellous bone grafting, and the Ilizarov inter-
calary bone transport method1. The application of these
methods results in successful final outcomes. However,
un-physiological bone repair, repeated surgical proce-
dures, long hospitalization time, prolonged ambulatory
impairment, and high medical costs are still common,
with functional and aesthetic con sequences. It is also
well known that concomitant diseases, such as diabetes,
can to some extent impair the healing of fractures, which
has been extensively studied in animals and less well in
humans2.
Recently, growth enhancers such as autologous pla-
telet rich plasma (PRP) in the form of activated platelet
gel and recombinant bone morphogenetic proteins (rBMP)
have been used with varying results for healing wounds,
ulcers, fractures, and in maxillofacial settings3. An ani-
mal study showed enhanced bone growth when autolo-
gous bone was combined with platelet-rich plasma4. The
healing effects of platelet gel were attributed to the nu-
merous growth factors (GFs) released by the platelets af-
ter activation5. Some of those identified are: the platelet
derived growth factor (PDGF), TGF-a and b (transform-
ing growth factor alpha and beta), EGF (epidermal
growth factor), FGF (fibroblast growth factor), IGF (in-
sulin growth factor), PDEGF (platelet derived epidermal
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growth factor), PDAF (platelet derived angiogenesis fac-
tor), IL-8 (interleukin-8), TNF-a (tumor necrosis factor
alpha), CTGR (connective tissue growth factor), GM-
-CSF (granulocyte macrophage colony stimulating fac-
tor), KGF (keratinocyte growth factor), and Ang-2 (an-
giopoetin), as reviewed by several authors. The inductive
potential of platelet gel in tissue regeneration could also
be attributed to its significant antimicrobial activity. Re-
cent studies on patients for the regeneration of long bone
and foot and ankle defects have provided promising clini-
cal results when using platelets as a source of GFs. It was
demonstrated that with the use of platelet gel as com-
pared to reconstruction with conventional methods,
better and stronger bone yield was achieved, and that
bone density and growth were enhanced6.
In the majority of clinical experiments, authors have
applied autologous platelets obtained by preoperative
apheresis from the peripheral blood of the patient under-
going surgery. However, this may not always be the best
solution. In cases of diabetes it has been shown that the
release of platelet GFs is decreased in experimental dia-
betic animals, and that allogeneic PRP as a source of ad-
ditional GFs can considerably improve diabetic fracture
healing7. Allogeneic single donor platelet units are easy
to obtain, since they are a standard blood bank product;
they are highly standardized in terms of platelet content,
residual leukocyte and red blood cell content, the centrif-
ugal forces used for their isolation, temperature of cen-
trifugation, techniques of separation and processing and
composition of preservative solution. Also, they are avail-
able in large quantities and considered safe. Autologous
platelet preparations, on the other hand, are subject to
enormous variability, which hinders serious studies of
their clinical efficacy.
We used the standard blood bank platelet concen-
trates in the preparation of a graft composed of alloge-
neic platelet gel mixed with autologous cancellous bone
in order to improve the healing conditions in bone de-
fects, which was successfully demonstrated in our pilot
clinical case8. In the latter case study, we showed that the
healing potential of the gel GFs obtained from a high
number of allogeneic platelets could be combined with
the bone-forming potential of autologous osteogenic and
other stem cells from the cancellous bone. We employed
the plasticity of the resulting graft mixture for the mod-
eling and all of this contributed to a successful clinical
outcome. In the present study, this method was further
tested in a series of nine patients.
Patients and Methods
Patients
Here we present the results of a prospective clinical
study performed from May 2004 to February 2010 in the
University Clinical Centre Ljubljana, Slovenia, in which
we have treated defected non-union of long bones using
allogeneic platelets as a source of GFs. Nine consecutive
patients (3 female and 6 male), age from 21 to 73 years
(average 45.9 years), each with a defect of a different long
bone (3 femoral, 4 tibial, 1 humeral and 1 ulnar). They
had already been unsuccessfully treated with conven-
tional methods in our or other hospitals for at least 9
months (Figure 1). The therapeutic options in these
cases had been exhausted. In two of the patients, we have
treated osteomyelitis before applying our treatment. We
took additional microbiological samples at the time of op-
eration. Two of the patients were insulin independent di-
abetics.
In our clinical investigation plan, the primary aim
was to establish the potency of allogeneic platelet gel
added to the transplanted autologous cancellous bone in
treatment of post-traumatic bone defect, with a follow-
-up of one year. The secondary aim was to assess the
healing, safety, handling and tolerance of the method,
and potential cost benefits.
We have noted all the important parameters in special
chart, the clinical and radiological examinations, during
the post-operative follow-up of one year. As a survey of
the immunological side effects of allogeneic platelets, we
performed a screening of HLA antibodies class I, and hu-
man platelet antibodies (HPA), before the implant opera-
tion and in the third month after the operation.
We prepared the cancellous bone from one or both pa-
tients’ iliac crests into particles smaller than 5 mm. A
standard allogeneic random single donor platelet concen-
trate (ABO and RhD matched, serologically HIV, HBV,
HCV and lues-negative, leukocyte depleted, and irradi-
ated) was added to cancellous bone in equal volume (allo-
geneic platelet concentrate with approximately 1.4 ´ 109
mL–1 with fibrin glue components for the activation of
platelets and polymerization of fibrinogen).
The bone defects were approached through previous
surgical incisions after administering a single dose of
prophylactic antibiotic. After debridement of the non-un-
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Fig. 1. The bone defect in distal tibia, after open comminuted
fracture, reduction, debridement and external fixation.
ion, we filled the resulting bone defect with a semi-solid,
moldable gelatinous graft and stabilized the bone with
different types of osteosinthesis (Table 1). We applied
suction drainage and closed the wound in layers.
In the follow-up protocol, we assessed the general sta-
tus after the operation, and the bone configuration with
X-ray at 2, 4, 6, and 12 months. We assessed bone remod-
eling at 6 and 12 months by CT scan. We drew blood sam-
ples from each patient at week 14 for the identification of
anti-HLA/Class I antibodies and anti-HPA antibodies in
order to assess potential immune reactions related to the
use of allogeneic platelets. The standard in-house pla-
telet immuno-fluorescence test (PIFT) and antigen cap-
ture ELISA test (PAK-12, GTI, Brookfield, USA) were
used to screen antibodies9.
Results
We removed suction drainage on the second or third
day after the surgery. The drainage volumes were in av-
erage 250±81 mL (200–450 mL). The patients were dis-
charged from the hospitals after 6–8 days, and they have
been regularly examined in the outpatients’ clinic.
Seven of nine patients have had complete bone in-
growths, with no defect. Different healing times are pre-
sented in Table 2.
We have noted major complications during the treat-
ment in three patients (33%); these were consisted of
poor incorporation of implant, mental deterioration lead-
ing to non-compliance, and radial nerve paresis (one pa-
tient respectively). Two of these patients had to undergo
further surgery. More detailed data of bone healing are
displayed in Table 3. No side effects caused by the im-
plant were observed; no platelet or HLA-class I antibod-
ies were detected in any patient.
The survival of the graft mixture was excellent; most
of the volume was preserved and incorporated. The struc-
ture of the graft was almost the same as neighboring
cancellous bone. The adjacent long bones have presented
no structural disintegration. This was critical in the case
of distal tibia (patients No 2, 3, 5, and 9), where we have
observed diminished incorporation in the distal part, due
to the fact that the metaphysis of the tibia is hypovascu-
larized. In the case of femur pseudarthrosis (patient No
6), bone quality was insufficient for the implant to regen-
erate the whole bone circumference, so healing was pro-
longed.
Discussion
Long bone defects are a pinnacle of deteriorated mor-
phology of a human bone. It is a culmination of patholog-
ical processes that weakened vascular supply. This leads
to decreased bone density, lower structural protein con-
tent in the bone adjacent to a bone defect.
The treatment of bone defects of long bones after in-
jury is still one of the most difficult tasks in reconstruc-
tive bone surgery. The golden standard in bone graft sur-
gery is still the use of autologous bone graft1. In certain
settings, especially in extensive bone defects, this me-
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TABLE 1
FIXATION METHODS USED AND GRAFT VOLUME PER PATIENT
Patient No. Pseudarthrosis site Fixation method
Defect size / Graft
volume in mL
1 Femur Internal locking plate 16
2 Distal tibia External fixator 35
3 Distal tibia Internal locking plate 45
4 Femur Tutor brace 15
5 Distal tibia Internal locking plate 30
6 Proximal femur Dynamic hip screw with long plate 25
7 Humerus Internal locking plate 35
8 Ulna External fixator 30
9 Distal tibia Internal locking plate 25
Average graft volume 28.5±9.5
TABLE 2
HEALING TIMES AFTER THE OPERATION FOR SUCCESSFUL CASES
Time in weeks for: Min Max X Median
Appearance of hazy callus 6 24 10.0±5.4 8
Partial weight bearing 12 40 22.5±10.4 18
Free mobility and full weight bearing 16 48 31.0±12.2 31
Overall bone healing 16 36 23.0±4.7 24
thod of treatment could be insufficient and could only
pose an additional trauma for the patient. Some authors
have reported difficulties when treating defected non-un-
ions, such as extremely long healing time and incorpora-
tion of the graft, necrosis of the grafts, and reacutisation
of infection10. Concomitantly, long-term immobilization
contributed to the contractures of the joints and soft tis-
sue, and in the long-term perspective, also to the inferior
functional and aesthetic results.
Reconstruction by vascularized bone transfer along
the Ilizarov intercalary bone transport and cancellous
bone grafting has been the most widely used method of
treatment for large defected non-unions after injury.
There have been several modifications of the Ilizarov
method, which retain its versatility, stability and me-
chanics, but these methods also contribute to a high rate
of complications10. Long treatment procedures deterio-
rate also soft tissues, leading to contractures and scars.
This influences unnatural position of joints, leading to
varus and valgus deviations of adjacent joints. Tissue en-
gineering involves the restoration of tissue structure or
function through the use of living cells. The general pro-
cess consists of cell isolation and proliferation, followed
by a re-implantation procedure in which a scaffold mate-
rial is used. Cell sources can be autologous or allogeneic
cells. Autologous cells are usually the better choice, be-
cause the allogeneic cells could incite immune rejection
by the recipient. Mesenchymal stem cells provide a good
alternative to cells from mature tissue and have a num-
ber of advantages as a cell source for bone and cartilage
tissue regeneration. Some authors report that most tis-
sue engineering applications in the head and neck area
would probably involve the use of chondrocytes and os-
teoblasts along with some type of scaffold material be-
cause of the importance of initial support and shaping11.
Theoretically, the ideal bone graft substitutes should
be osteogenic, biocompatible, bioabsorbable, able to pro-
vide structural support, easy to use clinically and cost-ef-
fective. A composite graft combines an osteoconductive
matrix with bioactive agents that provide osteoinductive
and osteogenic properties. Bone grafts are used to re-
place a part of the bony defect or to enhance the healing
of a fracture. Because of the inability to procure large
quantities of autologous bone and the added morbidity
for the patient associated with the autograft donor site,
new methods of bone transplant materials have emerged
in recent years. The functional properties of bone mor-
phogenetic proteins (BMP) 2 and 7, mesenchymal stem
cells (MSC), demineralised bone matrix, and biocompa-
tibile ceramics are presented in many papers describing
their use in bone defect treatment12. Bone morphoge-
netic proteins exhibit an extraordinary power to induce
new bone formation de novo without the presence of
cancellous bone13. With their high cost, limited availabil-
ity and restricted clinical indications, BMPs are a less at-
tractive option for clinical application. Synthetic substi-
tutes that provide a scaffold to support or direct bone
formation include calcium sulphate, ceramics, calcium
phosphate, cements, collagen, bioactive glass and syn-
thetic polymers. These are available in a variety of for-
mulations, including pellets, cement and injectable paste.
One of the clinical challenges in long bone defects is
the induction of appropriate bone formation, especially
in patients with diabetes. Several studies have demon-
strated the clinical efficacy of various platelet derived
GFs. Recent evidence shows that in diabetic patients
platelets are handicapped by decreased expression of
growth factors and lower potential for healing fracture.
The safety and efficacy of allogeneic platelets was also
shown in our recent pilot case study. Moreover, the prep-
aration of autologous platelet gel requires pre-operative
apheresis and blood draws from the patient, and adds to
the complexity, risk and cost of surgery14. Although there
is some evidence that the GFs are released to some ex-
tent in the stored platelet concentrates, the majority of
GFs remain intact in the platelet granules if they are ap-
propriately stored for up to 5 days15. Based on these
facts, we were of the opinion that allogeneic platelets
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1/F/63 8 12 40 Complete 16 None Healed
2/M/50 8 18 32 Bad prox. ingrowth 24 Left hip fract. Healed
3/F/49 10 16 – No distal. ingrowth 24 Reop. pseudart. Failed
4/M/45 24 32 44 Both ends half 28 None Healed








6/M/73 6 16 24 Complete 24 Short limb Healed
7/M/33 8 – 16 Complete 16 Radialis paresis Healed
8/M/21 12 – 16 Complete 16 None Healed
9/M/34 8 18 30 Complete 24 None Healed
constitute a superior alternative to autologous prepara-
tions obtained by pre-operative apheresis. Therefore, we
used a standard platelet concentrate from the blood bank
as a component for the activated platelet gel. In theory,
allogeneic platelets could have several certain side ef-
fects. In order to minimize these, all platelet units in our
study were leuko-depleted and irradiated in order to pre-
vent immune and bacteriological side effects, especially
alloimmunisation to HLA-Class I and HPA antigens16. In
fact, there was no evidence of immune reactions or trans-
fusion-transmitted infections following the procedures.
There have been no signs of bacterial contamination,
which is not strange, based on the recent observation
that the platelet gel exhibits significant antimicrobial ac-
tivity in vitro.
The combined autologous/allogeneic graft showed
successful incorporation into the defective pseudarthro-
sis in 7 out of 9 patients, which was confirmed with the
CT scans and plain X-ray film. The problem with the two
patients in whom the therapy failed was the poor incor-
poration of the graft in the distal tibia, where bone heal-
ing is compromised through many factors17. One of the
patients had a deteriorating psychiatric disorder and
could not follow instructions later in the study, and one
had a poor bone situation arising from previous treat-
ments. The other seven patients with successful out-
comes achieved a satisfactory clinical improvement with
no side effects related to the procedure. A bacterial infec-
tion did not reoccur in cases where an infection was pre-
viously treated. Our treatment has concluded a series of
numerous operations and rehabilitations for some of our
patients. Last, but not least, it is worth noticing that the
outdate rate of the platelet units is currently in the range
of 8–27% of all prepared platelet units. This leads to the
conclusion that the successful use of allogeneic platelets
would significantly decrease the amount of wasted plate-
lets, which could consequently favorably change the re-
sults of blood banking policies.
We showed that adding a platelet gel to a cancellous
bone graft can help achieve a good morphological result
of bone defect treatment. It retains grafted bone from re-
sorption and enhances its incorporation into adjacent
bone. The standard platelet concentrates from the blood
bank did not pose a significant risk for the affected pa-
tient. The results indicate good reasons for the applica-
tion of this method in the treatment of bone defects in
long bones. Further investigation is required to demon-
strate the comparative efficiency of this treatment. This
is the first report of a prospective clinical study monitor-
ing the use of allogeneic platelets mixed with autologous
cancellous bone for the treatment of the non-union of
long bones after fractures conducted at the University
Clinical Centre in Ljubljana. Our new method of tissue
engineering seems to have the potential to become a
widely approved and accepted method of bone tissue re-
placement in the treatment of the non-union of long
bones.
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UTJECAJ GELA PRIPRAVLJENOG OD ALOGENSKIH TROMBOCITA NA
OBLIK DUGIH KOSTIJU ^OVJEKA
S A @ E T A K
Cilj ovog rada je analizirati morfolo{ke i funkcionalne promjene na defektima dugih kostiju pacijenata nakon grafto-
vanja mje{avinom trombocita i autologne spongiozne kosti. Tokom jedne godine prospektivno je analizirano devet paci-
jenata starosti 25–73 godine sa pseudoartrozom duge kosti, nakon neuspje{nog inicijalnog kirur{kog tretmana. Mje{a-
vinom spongioze uzete sa grebena crijevne kosti i trombocitnog koncentrata ABO kompatibilne alogene plazme (PRP)
ispunjen je ko{tani defekt, i operativno fiksiran. Radiolo{ki, defekti su dobili ko{tani izgled (pojava tvrdog kalusa)
izmedju 6. i 24. tjedna. Vrijeme funkcionalnog oporavka je variralo; 12–40 tjedana bilo je potrebno do mogu}nosti par-
cijalnog oslonca, odnosno 16 do 48 tjedana do pune pokretljivosti i funkcionalnosti uda. Ukupno cijeljenje ko{tanog
defekta iznosilo je 16 do 36 tjedana. Dva pacijenta su imali komplikaciju u smislu slabog ko{tanog urastanja te prolazne
postoperativne pareze `ivca. Na RTG snimkama bila je vidljiva cjelovita i brza restauracija ko{tane strukture s odli~nim
ko{tanim prerastnjem, potrebnim za puni oslonac. Alogeni trombocitni gel nije imao {tetnih efekata. Ova metoda mo`e
se koristiti za lije~enje defekata dugih kostiju, obzirom na sna`nu restauraciju normalnog ko{tanog oblika. Budu}a
istra`ivanja su neophodna kako bi se usporedila u~inkovitost ove metode s drugim sli~nim metodama.
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